James Kent | Specialist Procurement Pharmacist London & East of England
NHS England

James Kent, Specialist Procurement Pharmacist  London & East of England, NHS England

James Kent worked for many years within the acute sector of the NHS, most recently as Clinical Lead Pharmacist and later Chief Pharmacist at Southend Hospital NHS Trust. From 2011-2017 he was also seconded to an organisation called PrescQIPP as the Secondary Care  Lead. This organisation seeks to support the NHS Medicines Optimisation agenda through the delivery of evidence based resources. This role allowed him to focus on a variety of key topics, the most significant of which was the introduction of biosimilars within the NHS.
James now works as the  Regional Medicines Procurement Specialist for London and the East of England. This position has allowed James to continue on his mission to maximise biosimilar usage for the benefit of both NHS providers and commissioners. This work is facilitated by his membership of the National Biosimilars Programme Board. He is also the Chair of the Branded and Biosimilars Subgroup which sits under the Pharmaceutical Market Support Group (PMSG).


Biosimilars Day 1 - Monday 29th October 2018 @ 09:20

International stakeholders panel discussion: What does it take to get biosimilars moving in a country?

    sting of industry panellists, physicians, pharmacists, patient advocacy groups, payers, regulators and health authorities, the 360° Perspective Panel allows the whole industry to come together to discuss and debate the sector’s most pertinent topics of the day.
  • With no guarantee that physicians will prescribe biosimilars interchangeably with reference products, what more does the industry need to do to encourage biosimilar uptake within healthcare?
  • What can we learn from gain-sharing practices? Carrot & stick models, which works better?
  • How influential are payers in the speed in which biosimilars are taken up in healthcare systems?
  • How does the industry envisage overcoming the challenge that patient communities are generally unaware of this new, yet important, category of medicines
last published: 16/Oct/18 13:05 GMT

back to speakers

There are two parts to the Festival of Biologics: the five world-class international conferences covering Antibodies, Immunotherapy, BioSimilars, Clinical Trials, and High Potency APIs; and an exhibition featuring the most exciting technology and solutions for pharma and biotech. There is a registration fee to attend the conferences. To visit the exhibition is free.

Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October 

Sign Up for Event Updates